Detection of nucleic acids

• US 8,206,904 B2
• Filed: 06/01/2007
• Issued: 06/26/2012
• Est. Priority Date: 12/18/2002
• Status: Expired due to Fees

• Current Assignee: Third Wave Technologies Incorporated (Hologic Incorporated)
• Original Assignee: Third Wave Technologies Incorporated (Hologic Incorporated)
• Inventors: Allawi, Hatim T., Lyamichev, Victor
• Primary Examiner(s): Babic, Christopher M.
• Application Number:
  US11/809,567
• Publication Number:
  US 20080131890A1
• Time in Patent Office: 1,852 Days
• Field of Search: None
• US Class Current: 435/6.1
• CPC Class Codes: C07H 21/02 with ribosyl as saccharide radical
• CPC Class Codes: C12Q 1/68 involving nucleic acids
• CPC Class Codes: C12Q 1/6816 characterised by the detection means C12Q1/6804 takes precedence
• CPC Class Codes: C12Q 2521/107 RNA dependent DNA polymerase,(i.e. reverse transcriptase)
• CPC Class Codes: C12Q 2525/161 incorporating target specific and non-target specific sites
• CPC Class Codes: C12Q 2561/109 Invader technology

Abstract

The present invention relates to compositions and methods for the detection and characterization of small nucleic acid molecules (e.g., RNA (e.g., small RNAs such as micro RNAs (miRNAs) and small interfering RNAs (siRNAs)) and other short nucleic acid molecules). More particularly, the present invention relates to methods for the detection and quantification of RNA expression. The present invention further provides for the detection of miRNA and siRNA variants.

Claims

1. A method for detecting an miRNA target, comprising:

a) providing;

i) a sample suspected of containing an miRNA target, said miRNA target comprising a first region, a second region, and a third region, wherein said first region is downstream of and contiguous to said second region, and wherein said second region is downstream of and contiguous to said third region;

ii) a first oligonucleotide that comprises a 3′

portion that is complementary to said first region of said miRNA target, and a 5′

portion that is not complementary to said miRNA target;

iii) a second oligonucleotide that comprises a 3′

portion that is substantially homologous to a said third region of said miRNA target and a 5′

portion that is not homologous to said third region of said miRNA target;

iv) a reverse transcriptase;

v) a DNA polymerase;

vi) a 5′

nuclease;

vii) a probe oligonucleotide, wherein at least a portion of said probe oligonucleotide is complementary to at least a portion of said second region of said miRNA target; and

viii) a first stacker oligonucleotide comprising a 5′

terminal portion, wherein at least the 5′

terminal portion of said stacker oligonucleotide is complementary to a region in said 5′

portion of said first oligonucleotide adjacent to said 3′

portion of said first oligonucleotide;

b) incubating components (i) through (viii) under conditions such that an invasive cleavage structure forms and is cleaved, wherein under said conditions;

1) said first oligonucleotide hybridizes to said miRNA target and said first stacker oligonucleotide and is extended by said reverse transcriptase to produce a first extended product complementary to said miRNA target;

2) said first extended product is amplified by polymerase chain reaction using said first oligonucleotide and said second oligonucleotide as primers to form an miRNA cDNA target;

3) said probe oligonucleotide and said first oligonucleotide hybridize to said miRNA cDNA target to form an invasive cleavage structure; and

4) said probe oligonucleotide in said invasive cleavage structure is cleaved by said 5′

nuclease to produce non-target cleavage product;

and

c) detecting cleavage of said probe oligonucleotide, wherein cleavage of said probe oligonucleotide is indicative of the presence of said miRNA target.

2. The method of claim 1, wherein components (i) through (viii) are combined in the same reaction vessel prior to said incubating.

3. The method of claim 1, wherein said 5′

nuclease is thermostable.

4. The method of claim 1, wherein said probe oligonucleotide is unlabeled and contains a 5′

and 3′

region, wherein said 3′

region is complementary to said second region of said miRNA target; and

wherein said 5′

region is non-complementary to said miRNA target and forms a 5′

flap.

5. The method of claim 1, wherein said 3′

portion of said first oligonucleotide forms a duplex of about 6-10 base pairs with said miRNA target during said incubating.

6. The method of claim 1, further comprising providing a second stacker oligonucleotide comprising a 5′

terminal portion, wherein at least the 5′

terminal portion of said second stacker oligonucleotide is complementary to a region of said 5′

portion said second oligonucleotide adjacent to said 3′

portion of said second oligonucleotide.

7. The method of claim 1, wherein said detecting comprises use of a labeled probe that is configured for FRET detection.

8. The method of claim 1, wherein said miRNA is selected from the group consisting of Let-7, miR-1, miR-135, miR-15, miR-16, miR125b, miR-1d, and miR124a.

9. The method of claim 1, wherein said 5′

nuclease comprises a modified DNA polymerase, wherein said modified DNA polymerase has 5′

nuclease activity but lacks synthetic activity.

10. The method of claim 4, further comprising providing an oligonucleotide cassette, wherein a portion of said oligonucleotide cassette is complementary to said 5′

region of said probe oligonucleotide, wherein said oligonucleotide cassette is configured to form an invasive cleavage structure with said non-target cleavage product from said cleavage of said probe oligonucleotide.

11. A method for detecting an miRNA target, comprising:

a) providing;

i) a sample suspected of containing an miRNA target, said miRNA target comprising a first region, a second region, and a third region, wherein said first region is downstream of and contiguous to said second region, and wherein said second region is downstream of and contiguous to said third region;

ii) a first oligonucleotide that comprises a 3′

portion that is complementary to said first region of said miRNA target, and a 5′

portion that is not complementary to said miRNA target;

iii) a second oligonucleotide that comprises a 3′

portion that is substantially homologous to a said third region of said miRNA target and a 5′

portion that is not homologous to said third region of said miRNA target;

iv) a reverse transcriptase;

v) a DNA polymerase;

vi) a FEN-1 endonuclease;

vii) a probe oligonucleotide, wherein at least a portion of said probe oligonucleotide is complementary to at least a portion of said second region of said miRNA target; and

viii) a first stacker oligonucleotide comprising a 5′

terminal portion, wherein at least the 5′

terminal portion of said stacker oligonucleotide is complementary to a region in said 5′

portion of said first oligonucleotide adjacent to said 3′

portion of said first oligonucleotide;

b) incubating components (i) through (viii) under conditions such that an invasive cleavage-structure forms and is cleaved, wherein under said conditions;

1) said first oligonucleotide hybridizes to said miRNA target and said first stacker oligonucleotide and is extended by said reverse transcriptase to produce a first extended product complementary to said miRNA target;

2) said first extended product is amplified by polymerase chain reaction using said first oligonucleotide and said second oligonucleotide as primers to form an miRNA cDNA target;

3) said probe oligonucleotide and said first oligonucleotide hybridize to said miRNA cDNA target to form an invasive cleavage structure; and

4) said probe oligonucleotide in said invasive cleavage structure is cleaved by said FEN-1 endonuclease to produce non-target cleavage product; and

c) detecting cleavage of said probe oligonucleotide, wherein cleavage of said probe oligonucleotide is indicative of the presence of said miRNA target.

12. The method of claim 11, wherein components (i) through (viii) are combined in the same reaction vessel prior to said incubating.

13. The method of claim 11, wherein said FEN-1 endonuclease comprises a thermostable FEN-1.

14. The method of claim 13, wherein said FEN-1 endonuclease is from an archaebacterium.

15. The method of claim 14, wherein said archaebacterium species is selected from the group consisting of:

Pyrococcus furiosus, Methanococcus jannaschii, Archaeoglobus veneficus and Archaeoglobus fulgidus.

16. The method of claim 11, wherein said probe oligonucleotide is unlabeled and contains a 5′

and 3′

region, wherein said 3′

region is complementary to said second region of said miRNA target; and

said 5′

region is non-complementary to said second region of said miRNA target and forms a 5′

flap.

17. The method of claim 16, further comprising an oligonucleotide cassette, wherein a portion of said oligonucleotide cassette is complementary to said 5′

region of said probe oligonucleotide, wherein said oligonucleotide cassette is configured to form an invasive cleavage structure with said non-target cleavage product from said cleavage of said probe oligonucleotide.

18. The method of claim 11, further comprising providing a second stacker oligonucleotide comprising a 5′

terminal portion, wherein at least the 5′

terminal portion of said second stacker oligonucleotide is complementary to a region of said 5′

portion said second oligonucleotide adjacent to said 3′

portion of said second oligonucleotide.

19. The method of claim 11, wherein said detecting comprises use of a labeled probe that is configured for FRET detection.

20. The method of claim 11, wherein said miRNA is selected from the group consisting of Let-7, miR-1, miR-135, miR-15, miR-16, miR125b, miR-1d, and miR124a.